Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bio Farma Measles-Rubella vaccine
- Development stage
- Unknown
- Lead developer
- Bio Farma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Bio Farma Measles-Rubella vaccine is a live attenuated combination vaccine developed by PT Bio Farma for the prevention of measles and rubella infections. It contains weakened strains of the measles and rubella viruses designed to elicit a protective immune response. The vaccine was evaluated in a Phase 2/3 randomized, observer-blind bridging study in healthy Indonesian infants aged 9-12 months to compare its immunogenicity and safety against the Serum Institute of India's (SII) registered MR vaccine. This development is part of Indonesia's effort to integrate locally produced vaccines into its National Program of Immunization.
- Other names
- MR Vaccine SII-PT Bio Farma-measles-rubellaMeasles-Rubella vaccine Bio FarmaBio Farma MR vaccine
Beyond the preview
Go deeper on Bio Farma Measles-Rubella vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio Farma Measles-Rubella vaccine.